Targeted Antibody Combo Spares Children Radiation in Hodgkin Lymphoma Study
A prospective Chinese pediatric study found that brentuximab vedotin combined with risk-adapted chemoimmunotherapy achieved 100 percent overall survival and allowed ...
A prospective Chinese pediatric study found that brentuximab vedotin combined with risk-adapted chemoimmunotherapy achieved 100 percent overall survival and allowed ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine